Huzefa Bhopalwala

Dr. Huzefa Bhopalwala

Mayo Clinic, Rochester, Indiana, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ZGZainab Gandhi
Zainab Gandhi
PGPriyatham Gurram
Priyatham Gurram
BABirendra Amgai
Birendra Amgai
SLSai Prasanna Lekkala
Sai Prasanna Lekkala
ALAlifya Lokhandwala
Alifya Lokhandwala
Salim SuraniSalim Surani
Salim Surani
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, emphasizing the need for improved diagnostic and treatment approaches. In recent years, the emergence of artificial intelligence (AI) has sparked considerable interest in its potential role in lung cancer. This review aims to provide an overview of the current state of AI applications in lung cancer screening, diagnosis, and treatment. AI algorithms like machine learning, deep learning, and radiomics have shown remarkable capabilities in the detection and characterization of lung nodules, thereby aiding in accurate lung cancer screening and diagnosis. These systems can analyze various imaging modalities, such as low-dose CT scans, PET-CT imaging, and even chest radiographs, accurately identifying suspicious nodules and facilitating timely intervention. AI models have exhibited promise in utilizing biomarkers and tumor markers as supplementary screening tools, effectively enhancing the specificity and accuracy of early detection. These models can accurately distinguish between benign and malignant lung nodules, assisting radiologists in making more accurate and informed diagnostic decisions. Additionally, AI algorithms hold the potential to integrate multiple imaging modalities and clinical data, providing a more comprehensive diagnostic assessment. By utilizing high-quality data, including patient demographics, clinical history, and genetic profiles, AI models can predict treatment responses and guide the selection of optimal therapies. Notably, these models have shown considerable success in predicting the likelihood of response and recurrence following targeted therapies and optimizing radiation therapy for lung cancer patients. Implementing these AI tools in clinical practice can aid in the early diagnosis and timely management of lung cancer and potentially improve outcomes, including the mortality and morbidity of the patients.

8 April 2022 in Current Problems in Cardiology
Verified
Journal Article
Closed access
AMAbdul Mannan Khan Minhas
Abdul Mannan Khan Minhas
Huzefa BhopalwalaHuzefa Bhopalwala
Huzefa Bhopalwala
NDNakeya Dewaswala
Nakeya Dewaswala
HSHusam M. Salah
Husam M. Salah
MKMuhammad Shahzeb Khan
Muhammad Shahzeb Khan
MFMarat Fudim
Marat Fudim

23 May 2022 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
DCDavid Chen
David Chen
Huzefa BhopalwalaHuzefa Bhopalwala
Huzefa Bhopalwala
NDNakeya Dewaswala
Nakeya Dewaswala
Shivaram P. ArunachalamShivaram P. Arunachalam
Shivaram P. Arunachalam
MEMoein Enayati
Moein Enayati
AAAdelaide M. Arruda-Olson
Adelaide M. Arruda-Olson
The analysis and interpretation of cardiac magnetic resonance (CMR) images are often time-consuming. The automated segmentation of cardiac structures can reduce the time required for image analysis. Spatial similarities between different CMR image types were leveraged to jointly segment multiple sequences using a segmentation model termed a multi-image type UNet (MI-UNet). This model was developed from 72 exams (46% female, mean age 63 ± 11 years) performed on patients with hypertrophic cardiomyopathy. The MI-UNet for steady-state free precession (SSFP) images achieved a superior Dice similarity coefficient (DSC) of 0.92 ± 0.06 compared to 0.87 ± 0.08 for a single-image type UNet (p < 0.001). The MI-UNet for late gadolinium enhancement (LGE) images also had a superior DSC of 0.86 ± 0.11 compared to 0.78 ± 0.11 for a single-image type UNet (p = 0.001). The difference across image types was most evident for the left ventricular myocardium in SSFP images and for both the left ventricular cavity and the left ventricular myocardium in LGE images. For the right ventricle, there were no differences in DCS when comparing the MI-UNet with single-image type UNets. The joint segmentation of multiple image types increases segmentation accuracy for CMR images of the left ventricle compared to single-image models. In clinical practice, the MI-UNet model may expedite the analysis and interpretation of CMR images of multiple types.

1 June 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Open access
AAArvin Arani
Arvin Arani
MMMatthew C. Murphy
Matthew C. Murphy
Huzefa BhopalwalaHuzefa Bhopalwala
Huzefa Bhopalwala
Shivaram P. ArunachalamShivaram P. Arunachalam
Shivaram P. Arunachalam
PRPhillip J. Rossman
Phillip J. Rossman
PAPhilip A. Araoz
Philip A. Araoz
Purpose To investigate the feasibility of using quantitative MR elastography (MRE) to characterize the influence of aging and sex on left ventricular (LV) shear stiffness. Materials and Methods In this prospective study, LV myocardial shear stiffness was measured in 109 healthy volunteers (age range: 18-84 years; mean age, 40 years ± 18 [SD]; 57 women, 52 men) enrolled between November 2018 and September 2019, using a 5-minute MRE acquisition added to a clinical MRI protocol. Linear regression models were used to estimate the association of cardiac MRI and MRE characteristics with age and sex; models were also fit to assess potential age-sex interaction. Results Myocardial shear stiffness significantly increased with age in female (age slope = 0.03 kPa/year ± 0.01, P = .009) but not male (age slope = 0.008 kPa/year ± 0.009, P = .38) volunteers. LV ejection fraction (LVEF) increased significantly with age in female volunteers (0.23% ± 0.08 per year, P = .005). LV end-systolic volume (LVESV) decreased with age in female volunteers (-0.20 mL/m2 ± 0.07, P = .003). MRI parameters, including T1, strain, and LV mass, did not demonstrate this interaction (P > .05). Myocardial shear stiffness was not significantly correlated with LVEF, LV stroke volume, body mass index, or any MRI strain metrics (P > .05) but showed significant correlations with LV end-diastolic volume/body surface area (BSA) (slope = -3 kPa/mL/m2 ± 1, P = .004, r2 = 0.08) and LVESV/BSA (-1.6 kPa/mL/m2 ± 0.5, P = .003, r2 = 0.08). Conclusion This study demonstrates that female, but not male, individuals experience disproportionate LV stiffening with natural aging, and these changes can be noninvasively measured with MRE. Keywords: Cardiac, Elastography, Biological Effects, Experimental Investigations, Sexual Dimorphisms, MR Elastography, Myocardial Shear Stiffness, Quantitative Stiffness Imaging, Aging Heart, Myocardial Biomechanics, Cardiac MRE Supplemental material is available for this article. Published under a CC BY 4.0 license.

1 February 2022 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
Huzefa BhopalwalaHuzefa Bhopalwala
Huzefa Bhopalwala
NDNakeya Dewaswala
Nakeya Dewaswala
SKSandhya Kolagatla
Sandhya Kolagatla
LWLauren Wisnieski
Lauren Wisnieski
JPJonathan Piercy
Jonathan Piercy
NMNagabhishek Moka
Nagabhishek Moka
Background: The prevalence and outcome of coronavirus disease 2019 (COVID-19) in rural areas is unknown. Methods: This is a multi-center retrospective cohort study of hospitalized patients diagnosed with COVID-19 from April 5, 2020 to December 31, 2020. The data were extracted from 13 facilities in the Appalachian Regional Healthcare system that share the same electronic health record using ICD-10-CM codes. Results: The number of patients diagnosed with COVID-19 per facility ranged from 5 to 535 with a median of 106 patients. Total mortality was 11.4% and ranged from 0% to 22.6% by facility (median: 9.0%). Non-survivors had a greater prevalence of congestive heart failure (CHF), hypertension, type 2 diabetes mellitus, stroke, transient ischemic attack (TIA), and pulmonary embolism. Patients who died were also more likely to have had chronic obstructive pulmonary disease (COPD), acute respiratory failure (ARF), liver cirrhosis, chronic kidney disease (CKD), dementia, cancer, anemia, and opiate dependence. Conclusion: The aging population, multiple co-morbidities, and health-related behaviors make rural patients vulnerable to COVID-19. A better understanding of the disease in rural areas is crucial, given its heightened vulnerability to adverse outcomes.

22 August 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
MPMichelle Partogi
Michelle Partogi
SGSimon Gaviria-Valencia
Simon Gaviria-Valencia
MAMateo Alzate Aguirre
Mateo Alzate Aguirre
NPNancy Pick
Nancy Pick
Huzefa BhopalwalaHuzefa Bhopalwala
Huzefa Bhopalwala
AAAdelaide Arruda-Olson
Adelaide Arruda-Olson
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Clinical practice guidelines recommend antiplatelet and statin therapies, as well as blood pressure control and tobacco cessation for secondary prevention in patients with established atherosclerotic cardiovascular diseases (ASCVDs). However, these strategies for risk modification are underused especially in rural communities. Moreover, resources to support delivery of preventive care to rural patients are less than their urban counterparts. Transformative interventions for delivery of tailored preventive cardiovascular care to rural patients are needed. Objective: A multidisciplinary team developed a rural-specific, team-based care intervention assisted by clinical decision support (CDS) technology using participatory design in a sociotechnical conceptual framework. The intervention included redesigned workflows and a novel CDS technology for coordination and delivery of guideline recommendations by primary care teams in a rural clinic. Methods: Intervention design was comprised of three phases: (I) problem identification, (II) experimentation and (III) testing. Input from team members (n=35) required 150 hours, including observations of clinical encounters, provider workshops and interviews of patients and health care professionals. The intervention was prototyped, iteratively refined, and tested with user feedback. In a three-month pilot trial, 369 ASCVD patients were randomized to control or intervention arms. Results: New workflows and a novel CDS tool were created to identify ASCVD patients with gaps in preventive care and assign the right care team member for delivery of tailored recommendations. During the pilot the intervention prototype was iteratively refined and tested. The pilot demonstrated feasibility for successful implementation of the sociotechnical intervention as the proportion of patients who had encounters with advance practice providers (nurse practitioners/physician assistants), pharmacists, or tobacco cessation coaches for delivery of guideline recommendations in the intervention arm was greater compared to the control arm. Conclusions: Participatory design and a sociotechnical conceptual framework enabled development of a rural-specific, team-based care intervention assisted by CDS technology for transformation of preventive health care delivery for ASCVDs.